全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
-  2017 

TRX1与JAB1在急性髓系白血病中的表达及其相关性
Relationship between TRX1 and JAB1 in acute myelogenous leukemia

DOI: 10.7652/jdyxb201701013

Keywords: 急性髓系白血病,硫氧还蛋白1,C-Jun激活区结合蛋白1
acute myelogenous leukemia
,thioredoxin (TRX1),c-jun-activation-domain binding protein-1 (JAB1)

Full-Text   Cite this paper   Add to My Lib

Abstract:

摘要:目的 探讨硫氧还蛋白1(TRX1)和c-Jun激活区结合蛋白1(JAB1)在白血病各组中的表达,及TRX1水平在急性髓系白血病(AML)各组中的表达及其临床意义。方法 应用RT-PCR及Western blot的方法对白血病患者TRX1和JAB1的表达进行检测,比较各组之间的差异;进一步分析AML患者其基因表达阳性率与外周血白细胞计数的关系,并采用ELISA方法检测以上血清样本的TRX1水平。结果 在白血病患者中TRX1和JAB1基因和蛋白表达明显高于对照组(P<0.05),相关分析显示AML初发和复发病例中TRX1和JAB1表达相关程度高,而且高表达的TRX1和JAB1与外周血白细胞计数有关(P<0.05);ELISA检测外周血TRX1在AML的复发组高于初发组和对照组,初发组高于对照组,差异具有统计学意义(P<0.05)。结论 TRX1和JAB1之间呈正向关联,与AML的发生及病情进展有密切关系。
ABSTRACT: Objective To detect the expressions of thioredoxin (TRX1) and c-jun-activation-domain binding protein-1 (JAB1) in patients with acute myelogenous leukemia (AML) and healthy controls, and measure the TRX1 level in AML patients at different stages for evaluating its clinical significance. Methods The expressions of TRX1 and JAB1 in leukemia samples were analyzed by RT-PCR and Western blot at mRNA and protein levels, respectively. The correlation between TRX1 and JAB1, and the relationship between the gene expression and peripheral blood leukocytes count were also analyzed. Furthermore, serum TRX1 was measured by ELISA. Results TRX1 and JAB1 expressions at both mRNA and protein levels were obviously upregulated in leukemia patients (P<0.05). TRX1 was positively related to JAB1 in both newly diagnosed and recurrent AML patients. And high levels of TRX1 and JAB1 expressions were associated with white blood cell (WBC) counts in AML patients (P<0.05). Moreover, abundance of TRX1 in serum was significantly greater in AML patients, especially in the patients with recurrent AML, than in healthy donors (P<0.05). Conclusion There is a positive correlation between the expressions of TRX1 and JAB1, which is closely related to the occurrence and progression of AML

References

[1]  JAMIL K, MUSTAFA SM. Thioredoxin system: a model for determining novel lead molecules for breast cancer chemotherapy[J]. Avicenna J Med Biotechnol, 2012, 4(3):121-130.
[2]  KILIC N, YAVUZ TASLIPINAR M, GUNEY Y, et al. An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer[J]. Ann Surg Oncol, 2014, 21(13):4139-4143.
[3]  史娜娜,吴博文,孙慧,等. t(8;21)急性髓系白血病的临床特征及预后分析[J]. 郑州大学学报(医学版), 2016, 51(3):409-412.
[4]  ZHOU FL, ZHANG WG, WEI YC, et al. Involvement of oxidative stress in the relapse of acute myeloid leukemia[J]. J Biol Chem, 2010, 285(20):15010-15015.
[5]  WANG Y, YU YN, SONG S, et al. JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis[J]. J Cancer Res Clin Oncol, 2014, 140(6):969-978.
[6]  GUO Z, LV Q, ZHANG Y, et al. Expression and significance of c-Jun activation domain binding protein 1 in human colorectal carcinoma[J]. Zhonghua Yi Xue Za Zhi, 2014, 94(12):899-902.
[7]  MAHMOOD DF, ABDERRAZAK A, El HADRI K, et al. The thioredoxin system as a therapeutic target in human health and disease[J]. Antioxid Redox Signal, 2013, 19(11):1266-1303.
[8]  PAN Y, YANG H, CLARET FX. Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer[J]. Cancer Biol Ther, 2014, 15(3):256-262.
[9]  罗琼,黄志新,罗柳萍,等. trx-2基因表达在急性白血病微小残留病灶监测中的作用[J]. 中南大学学报(医学版), 2013, 38(4):383-387.
[10]  YANG KT, WANG MC, CHEN JY, et al. Bcr-Abl oncogene stimulates Jab1 expression via cooperative interaction of β-catenin and STAT1 in chronic myeloid leukemia cells[J]. J Cell Physiol, 2011, 226(11):2849-2856.
[11]  李倩,李劲高,周茂华,等. 白血病细胞CD56抗原表达与急性髓系白血病患者预后的关系[J]. 吉林大学学报(医学版), 2016, 42(2):283-289.
[12]  CLARET FX, HIBI M, DHUT S, et al. A new group of conserved coactivators that increase the specificity of AP-1 transcription factors[J]. Nature, 1996, 383(6599):453-457.
[13]  MORI M, YONEDA-KATO N, YOSHIDA A, et al. Stable form of JAB1 enhances proliferation and maintenance of hematopoietic progenitors[J]. Biol Chem, 2008, 283(43):29011-29021.
[14]  BERGHELLA AM, PELLEGRINI P, DEL BEATO T, et al. The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy[J]. Cancer Immunol Immunother, 2011, 60(10):1373-1381.
[15]  RACKHAM O, SHEARWOOD AM, THYER R, et al. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors[J]. Free Radic Biol Med, 2011, 50(6):689-699.
[16]  DENG ZH, CAO HQ, HU YB, et al. TRX is up-regulated by fibroblast growth factor-2 in lung carcinoma[J]. APMIS, 2011, 119(1):57-65.
[17]  CHEN L, YUAN D, WANG GL, et al. Clinicopathological significance of expression of Tspan-1, Jab1 and p27 in human hepatocellular carcinoma[J]. J Korean Med Sci, 2010, 25(10):1438-1442.
[18]  NISHIMOTO A, KUGIMIYA N, HOSOYAMA T, et al. JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells[J]. Biochem Biophys Res Commun, 2013, 438(3):513-518.
[19]  PAN Y, ZHANG Q, TIAN L, et al. Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma[J]. Cancer Res, 2012, 72(7):1890-1900.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133